Proteolytic cleavage of chromogranin A (CgA) by plasmin. Selective liberation of a specific bioactive CgA fragment that regulates catecholamine release.
about
The plasminogen activation system and the regulation of catecholaminergic functionChromogranin A and cortisol at intraoperative repeated noxious stimuli: Surgical stress in a dog modelThe anti-fibrinolytic SERPIN, plasminogen activator inhibitor 1 (PAI-1), is targeted to and released from catecholamine storage vesiclesCathepsin L colocalizes with chromogranin a in chromaffin vesicles to generate active peptidesProteomics-based discovery of a novel, structurally unique, and developmentally regulated plasminogen receptor, Plg-RKT, a major regulator of cell surface plasminogen activationNew insights into the role of Plg-RKT in macrophage recruitment.Catestatin: a multifunctional peptide from chromogranin ABoth rare and common polymorphisms contribute functional variation at CHGA, a regulator of catecholamine physiology.Naturally occurring genetic variants in human chromogranin A (CHGA) associated with hypertension as well as hypertensive renal disease.Engineering kunitz domain 1 (KD1) of human tissue factor pathway inhibitor-2 to selectively inhibit fibrinolysis: properties of KD1-L17R variantThe novel plasminogen receptor, plasminogen receptor(KT) (Plg-R(KT)), regulates catecholamine release.Regulation of macrophage migration by a novel plasminogen receptor Plg-R KT.Proteolytic cleavage of human chromogranin a containing naturally occurring catestatin variants: differential processing at catestatin region by plasmin.Novel peptide isomer strategy for stable inhibition of catecholamine release: application to hypertensionA new chromogranin A-dependent angiogenic switch activated by thrombin.The neuroendocrine peptide catestatin is a cutaneous antimicrobial and induced in the skin after injury.Plasminogen receptors: the first quarter century.Peptidergic regulation of plasminogen activator inhibitor-1 gene expression in vivo.Chromogranin B: intra- and extra-cellular mechanisms to regulate catecholamine storage and release, in catecholaminergic cells and organisms.Does plasmin have anticoagulant activity?Natural and engineered plasmin inhibitors: applications and design strategies.Cell surface remodeling by plasmin: a new function for an old enzyme.Chromogranin A as a biomarker in cardiovascular disease.Chromogranin A and its fragments as regulators of small intestinal neuroendocrine neoplasm proliferation.Chromogranin A Regulation of Obesity and Peripheral Insulin Sensitivity.Conformationally organized lysine isosteres in Streptococcus pyogenes M protein mediate direct high-affinity binding to human plasminogen.Cleavage of chromogranin A N-terminal domain by plasmin provides a new mechanism for regulating cell adhesion.Cathepsin L expression is directed to secretory vesicles for enkephalin neuropeptide biosynthesis and secretion.Plasminogen regulates pro-opiomelanocortin processing.Glycosylated Chromogranin A: Potential Role in the Pathogenesis of Heart Failure.Plasminogen gene expression is regulated by nerve growth factor.Catestatin as a Target for Treatment of Inflammatory Diseases
P2860
Q26862632-C535017A-2BDB-4596-A8FC-57E997285316Q28272056-651561F5-D18A-4F87-B04C-5D2819EF1CF1Q28579043-E5DC7E57-20C6-4758-8A0D-109365A8D25CQ28579762-F2EE886E-4D1C-4D37-B588-D3B09F845096Q28591912-8173458A-CCFF-43F0-AF17-F6DF57673B78Q33768031-AEF7B53E-DD37-4ECF-AD57-12F577870A26Q33838302-208AED4B-6AA3-45B0-949A-E7903DC2492CQ33909582-CA887A9E-F3A2-408F-AB84-7D1C0A12F45FQ34435126-4183AB09-5DEF-43A6-BDA8-FA26CB1BB210Q34575895-9880299F-E1A9-42BB-BB07-4836470B53F1Q35312511-626DFD38-39E2-40B3-9012-B696B9AF3A5EQ35553363-42BEBDE6-7293-43F3-90BB-DD569B034410Q36415854-0D3299EB-7400-4DBE-8C18-DFEBF85FF81BQ36470847-16CA62EF-0E60-420C-9A07-2EA373736C7EQ36529507-5A62B785-9631-4085-87C6-2D561C705A86Q37375312-B82EB5F7-4DC9-4C15-9244-1D9A1C21D4A2Q37609916-F5DCD022-D843-49DA-B504-3CF06BC801E8Q37662254-FE7EA368-22CC-4F30-A3AC-1275BFE41045Q37711228-FD74051A-5DA9-436F-9263-FD4B0E84941CQ37734885-17938676-5787-4DCA-86EB-4D74E33A1A66Q37975189-F9AD1FA9-D89C-45C9-8884-C669E670C9F0Q38055477-A73CC909-B613-43A7-BA3C-A047194A2696Q38170143-353A3CCB-0950-4516-84E7-D2630CA12072Q39059601-BC062EF3-E903-4F5D-ABDA-1FB1E1FB1778Q39147191-3C1AD822-1595-4057-8C11-F0F4002C8B72Q39620014-49CE548F-23A4-4D6D-B739-ECF92FEB82C5Q42810043-A545D791-436E-40FF-86D1-9829D15D5206Q44754448-0EB4F684-4630-41D8-88DF-0F27C839BD0CQ44852518-739C65EC-3496-41F4-B75C-34281B66F3B3Q47702359-E482C098-FC19-4DAA-90A2-ACA07E787EFDQ53537278-993FDDD7-9C5C-4245-AB31-75E0B5070C84Q58583898-EB9F56BA-1E49-44EB-AB80-F78F7CB524F9
P2860
Proteolytic cleavage of chromogranin A (CgA) by plasmin. Selective liberation of a specific bioactive CgA fragment that regulates catecholamine release.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Proteolytic cleavage of chromo ...... gulates catecholamine release.
@ast
Proteolytic cleavage of chromo ...... gulates catecholamine release.
@en
type
label
Proteolytic cleavage of chromo ...... gulates catecholamine release.
@ast
Proteolytic cleavage of chromo ...... gulates catecholamine release.
@en
prefLabel
Proteolytic cleavage of chromo ...... gulates catecholamine release.
@ast
Proteolytic cleavage of chromo ...... gulates catecholamine release.
@en
P2093
P2860
P356
P1476
Proteolytic cleavage of chromo ...... gulates catecholamine release.
@en
P2093
O'Connor DT
Taupenot L
P2860
P304
25022-25029
P356
10.1074/JBC.M101545200
P407
P577
2001-05-07T00:00:00Z